@FierceMedDev: ICYMI yesterday: Medtronic gets EU regulatory green light for $43 billion merger with Covidien. Article | Follow @FierceMedDev
@EmilyWFierce: Roche acquires prenatal diagnostics outfit Ariosa. Press release | Follow @EmilyWFierce
> Three-month-old medical device startup Aortica raised $7 million in a Series A funding round to use toward its 3-D-printed surgical grafting tool. Story
> The controversial DNA spit test developed and sold by 23andMe was given a tentative marketing go-ahead in the U.K. Read
> Minimally invasive surgical device company Interrad Medical closed a financing round with $7.5 million. Release
> Aethlon Medical, a therapeutic device developer targeting infectious disease and cancer, reported results of the use of its Hemopurifier device to treat hepatitis C patients. It is preparing to launch its first U.S. human clinical studies on HCV patients. Release
Biotech News
@FierceBiotech: From FierceBiotechIT: Texas' $3B cancer agency makes computational biology a priority. Article | Follow @FierceBiotech
@JohnCFierce: I wonder if someone would pay me $3.5B for Uncle John's Quiet Time Elixir. (Nyquil and bourbon). $AVNR. | Follow @JohnCFierce
@DamianFierce: Tim Duncan donated $247K to help sequence the genomes of 1,000 cancer patients and publicize the results. Article | Follow @DamianFierce
> J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III. News
> GeNeuro snags a $455M deal, inks MS drug pact with Servier. More
> Otsuka buys Avanir and its portfolio of repurposed generics for $3.5B. Story
> Ascendis banks $60M to get its orphan drug into Phase III. Article
Pharma News
@FiercePharma: NICE changes its attitude on Roche's Gazyvaro. Item | Follow @FiercePharma
@CarlyHFierce: Reuters: In Fresenius, Danone could lose second suitor for nutrition unit. More | Follow @CarlyHFierce
> BMS makes cuts in China, reports say up to 1,000. Article
> Otsuka spends $3.5B for Avanir--and patent-cliff protection. Story
> NICE changes its attitude on Roche's Gazyvaro. More
Biotech Research News
> New structural biology software tackles viruses and bacteria. Story
> 8-year study highlights role of a key protein in cardiomyopathy. More
> Binge drinking 'cure' in rats sparks a debate over animal study. Story
> Cell research at Brigham & Women's points to a new drug target for fibrosis. Report
> Harvard, MIT teams identify a 'pre-malignant' phase for blood cancers. Article
Pharma Manufacturing News
> Lyophilization market forecast to double in size by 2020. Article
> FDA slaps Dr. Reddy's with a Form 483. Report
> Eisai opens new plants targeting Asia and Europe. More
> Italy clears Novartis vaccine manufacturing in deaths following vaccinations. Story
> Recipharm expands footprint, buys Flamel facility in France for $13.2M. Article